NCT04458831: A Non-interventional, Multinational, Observational study With Isatuximab in RRMM

IONA-MM

NCT04458831: A Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) (IONA-MM)

NCT04458831: A Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) (IONA-MM)

To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months

Sponsor

Sanofi

---

ClinicalTrials.gov Identifier: NCT04458831

Official Title: A Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

First Posted : July 7, 2020

Click here to see details on ClinicalTrials.gov

---

Drug: isatuximab SAR650984

Drug: Pomalidomide

Drug: Dexamethasone

Drug: Carfilzomib

---

Isatuximab : National Cancer Institute

Isatuximab : MedlinePlus Drug Information

---

Locations